`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`STEADYMED LTD.
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORPORATION
`Patent Owner
`
`U.S. Patent No. 8,497,393
`Issue Date: Jul. 30, 2013
`Title: PROCESS TO PREPARE TREPROSTINIL, THE ACTIVE
`INGREDIENT IN REMODULIN®
`_______________
`
`Case IPR2016-00006
`_______________
`
`
`
`
`
`Patent Owner’s Mandatory Notices
`37 C.F.R. § 42.8
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`4851-2470-5065.1
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
` Patent Owner hereby files its Mandatory Notices under 37 C.F.R. § 42.8(a)(2).
`
`The Notices are being timely filed within 21 days of service of the Petition, which
`
`was served on Oct. 2, 2015.1
`
`REAL PARTY-IN-INTEREST
`
`United Therapeutics Corp. is the assignee of US Patent No. 8,497,393 (“the
`
`’393 patent”) based on a recorded assignment.
`
`RELATED MATTERS
`
`Patent Owner has asserted the ’393 patent in the following civil actions filed in
`
`the District Court of New Jersey:
`
`(a) United Therapeutics Corp. v. Sandoz, Inc., Civ. No. 14-cv-05499;
`
`(b) United Therapeutics Corp. v. Teva Pharmaceuticals, U.S.A., Inc., Civ. No.
`
`14-cv-05498; and
`
`(c) United Therapeutics Corp. v. Watson Laboratories, Inc., Civ. No. 15-cv-
`
`05723.
`
`
`
`1 The certificate of service attached to the petition incorrectly indicates a service
`
`date of Oct. 1, 2015. The actual date of mailing by express mail is Oct. 2, 2015, as
`
`indicated in Petitioner’s cover letter and express mail packaging.
`
`4851-2470-5065.1
`
`2
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`In addition, US Patent Application Ser. Nos. 14/754,932 and 14/849,981,
`
`claiming priority to the ’393 patent, are currently pending.
`
`LEAD AND BACKUP COUNSEL
`
`Lead Counsel:
`
`Stephen B. Maebius
`Foley & Lardner LLP
`3000 K St., NW., Suite 600
`Washington, DC 20007
`Direct Line: 202-672-5569
`Email: smaebius@foley.com
`Fax: 202-672-5399
`USPTO Reg. No. 35,264
`
`Backup Counsel:
`
`
`
`George Quillin
`Foley & Lardner LLP
`3000 K St., NW., Suite 600
`Washington, DC 20007
`Direct Line: 202-672-5413
`Email: gquillin@foley.com
`Fax: 202-672-5399
`USPTO Reg. No. 32,792
`
`Shaun R. Snader
`United Therapeutics Corp.
`1735 Connecticut Ave., NW, 2nd Floor
`Washington, DC 20009
`Direct Line: 202-304-1701
`Email: ssnader@unither.com
`USPTO Reg. No. 59,987
`
`4851-2470-5065.1
`
`3
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Patent Owner Docket No. 080618-1601
`
`
`
`Douglas Carsten
`Wilson, Sonsini, Goodrich & Rosati
`12235 El Camino Real
`Suite 200
`San Diego, CA 92130
`Direct Line: 858-350-2305
`Email: dcarsten@wsgr.com
`Fax: 858-350-2399
`Reg. No. 43,534
`
`Richard Torczon
`Wilson, Sonsini, Goodrich & Rosati
`1700 K St., NW
`Washington, DC 20006
`Direct Line: 202-973-8811
`Email: rtorczon@wsgr.com
`Fax: 202-973-8899
`Reg. No. 34,448
`
`Robert Delafield
`Wilson, Sonsini, Goodrich & Rosati
`900 South Capital of Texas Hwy
`Las Cimas IV, Fifth Floor
`Austin, TX 78746
`Direct Line: 512-338-5432
`Email: bdelafield@wsgr.com
`Fax: 512-338-5499
`Reg. No. 64,709
`
`4851-2470-5065.1
`
`4
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`SERVICE INFORMATION
`
`Patent Owner Docket No. 080618-1601
`
`
`
`Please address all correspondence to the lead counsel at the address shown
`
`above. Patent Owner consents to electronic service by e-mail at:
`
`UT393-IPR@foley.com.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`Date: October 19, 2015
`
`
`
`
`
`
`
`4851-2470-5065.1
`
`5
`
`
`
`IPR2016-00006
`Patent 8,497,393
`
`
`Attorney Docket No. 080618-1601
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Mandatory Notices was served on counsel of record on October 19, 2015
`
`by filing this document through the Patent Review Processing System as well as
`
`delivering a copy via email to the counsel of record for the Petitioner at the
`
`following address: Steadymed-IPR@dlapiper.com
`
`
`
`
`
`
`
`
`
`
`/Stephen B. Maebius/
`
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: October 19, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`4821-7011-5112.1